Sequenom, Inc. (NASDAQ:SQNM) Received Premarket Clearance From The USFDA

Boston, MA 06/17/2014 (wallstreetpr) – Sequenom, Inc. (NASDAQ:SQNM) on June 16, 2014 announced that the United States Food and Drug Administration (FDA) gave premarket 510(k) clearance to market the company’s IMPACT Dx(TM) Factor V Leiden and Factor II Genotyping Test and the IMPACT Dx(TM) System. What Is IMPACT Dx Factor V Leiden And Factor II […]

Sequenom, Inc. (NASDAQ:SQNM) Received FDA Premarket Clearance

Boston, MA 06/17/2014 (wallstreetpr) – The life science company, Sequenom, Inc. (NASDAQ:SQNM) on June 16, 2014 declared that it has been given premarket 510(k) clearance from FDA (Food and Drug Administration of the U.S.). FDA clearance: The United States’ Food and Drug Administration has given Sequenom the premarket 510(k) clearance to market the IMPACT Dx […]

Sequenom Inc. (NASDAQ:SQNM) Hits Record revenue in Q1

Boston, MA 05/02/2014 (wallstreetpr) – Molecular diagnostic testing and genetics company, Sequenom Inc. (NASDAQ:SQNM), is surging in early morning trading after beating estimates with its first quarter results, having posted record revenues. Sequential growth continues to be experienced in better than expected volumes of revenue, gross margin and expenses. Steady growth continue to ensure the company […]

Sequenom, Inc. (NASDAQ:SQNM) Notifies IMPACT DX System And Others

Boston, MA 10/18/2013 (wallstreetpr) – Sequenom, Inc. (NASDAQ:SQNM) an innovator in the clinical research and clinical molecular diagnostic instrumentation, technology and tests has notified two of its latest products: “IMPACT Dx™ System and its IMPACT Dx™ Factor V Leiden and Factor II Genotyping Test” with FDA, in early October. Both the system and the test are […]

Sequenom Inc (NASDAQ:SQNM)’s shares down by 29.64%

Boston, MA 07/26/2013 (wallstreetpr) – On behalf of the security purchasers of Sequenom Inc (NASDAQ:SQNM), the potential claims is being investigated by Howard G. Smith law offices. These claims are concerning the possibilities of violations of the laws of federal securities. These investigations has its’ focus on the certain statements which are concerning the company’s operations […]